MADRIGAL PHARMACEUTICALS INC's ticker is and the CUSIP is 558868955. A total of 7 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,219 | -62.9% | 15,200 | -41.3% | 0.00% | -60.0% |
| Q2 2023 | $5,982 | +21.0% | 25,900 | +27.0% | 0.01% | +25.0% |
| Q1 2023 | $4,942 | -60.3% | 20,400 | -52.4% | 0.00% | -71.4% |
| Q4 2022 | $12,451 | -97.0% | 42,900 | +581.0% | 0.01% | – |
| Q3 2022 | $409,000 | +46.6% | 6,300 | +61.5% | 0.00% | – |
| Q2 2022 | $279,000 | -61.6% | 3,900 | -47.3% | 0.00% | -100.0% |
| Q1 2022 | $726,000 | +218.4% | 7,400 | +174.1% | 0.00% | – |
| Q4 2021 | $228,000 | +1100.0% | 2,700 | +1250.0% | 0.00% | – |
| Q3 2021 | $19,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | -17.4% | 200 | +9900.0% | 0.00% | – |
| Q1 2021 | $23,000 | +4.5% | 2 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | -98.8% | 2 | -98.7% | 0.00% | -100.0% |
| Q3 2020 | $1,875,000 | -27.4% | 158 | -30.7% | 0.00% | -25.0% |
| Q2 2020 | $2,582,000 | +41.2% | 228 | -16.8% | 0.00% | +33.3% |
| Q1 2020 | $1,829,000 | +8.5% | 274 | +48.1% | 0.00% | -25.0% |
| Q4 2019 | $1,685,000 | +124.7% | 185 | +112.6% | 0.00% | +100.0% |
| Q3 2019 | $750,000 | +5.3% | 87 | +27.9% | 0.00% | 0.0% |
| Q2 2019 | $712,000 | -70.1% | 68 | -64.2% | 0.00% | -71.4% |
| Q1 2019 | $2,379,000 | +251.9% | 190 | +216.7% | 0.01% | +250.0% |
| Q4 2018 | $676,000 | -4.2% | 60 | +81.8% | 0.00% | 0.0% |
| Q3 2018 | $706,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 129,400 | $18,897,576 | 0.06% |
| JANE STREET GROUP, LLC | 194,300 | $28,375,572 | 0.01% |
| SIMPLEX TRADING, LLC | 15,200 | $2,219 | 0.00% |
| JPMORGAN CHASE & CO | 115,700 | $16,896,828 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |